Misplaced Pages

Ponazuril: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 19:35, 26 December 2013 editAnypodetos (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers39,350 edits Refs; drugbox additions← Previous edit Revision as of 22:43, 12 July 2014 edit undoVanisaac (talk | contribs)Autopatrolled, Extended confirmed users92,685 edits template:Pmid -> template:Cite pmid per Misplaced Pages:Redirects for discussion/Log/2014 July 2#Template:Pmid, replaced: {{pmid → {{cite pmid using AWBNext edit →
Line 45: Line 45:
}} }}


'''Ponazuril''' (]), sold by the ] under the trade name '''Marquis''', is a drug currently approved for the treatment of ] (EPM) in horses, caused by ''] neurona''.<ref>Marquis {{drugs.com|pro|marquis}}</ref><ref>{{pmid|18312139}}</ref> More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against ], an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM. '''Ponazuril''' (]), sold by the ] under the trade name '''Marquis''', is a drug currently approved for the treatment of ] (EPM) in horses, caused by ''] neurona''.<ref>Marquis {{drugs.com|pro|marquis}}</ref><ref>{{cite pmid|18312139}}</ref> More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against ], an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.


==See also== ==See also==

Revision as of 22:43, 12 July 2014

Pharmaceutical compound
Ponazuril
Clinical data
Trade namesMarquis
AHFS/Drugs.comFDA Professional Drug Information
Routes of
administration		Oral
ATCvet code
Legal status
Legal status
Identifiers
IUPAC name
  • 1-Methyl-3-phenyl]-1,3,5-triazinane-2,4,6-trione
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.157.907 Edit this at Wikidata
Chemical and physical data
FormulaC18H14F3N3O6S
Molar mass457.380 g/mol g·mol
3D model (JSmol)
SMILES
  • CC1=C(C=CC(=C1)N2C(=O)NC(=O)N(C2=O)C)OC3=CC=C(C=C3)S(=O)(=O)C(F)(F)F
InChI
  • InChI=1S/C18H14F3N3O6S/c1-10-9-11(24-16(26)22-15(25)23(2)17(24)27)3-8-14(10)30-12-4-6-13(7-5-12)31(28,29)18(19,20)21/h3-9H,1-2H3,(H,22,25,26)
  • Key:VBUNOIXRZNJNAD-UHFFFAOYSA-N
  (verify)

Ponazuril (INN), sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.

See also

References

  1. Marquis FDA Professional Drug Information
  2. Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18312139, please use {{cite journal}} with |pmid=18312139 instead.


Stub icon

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This veterinary medicine–related article is a stub. You can help Misplaced Pages by expanding it.

Categories: